WEKO3
アイテム
{"_buckets": {"deposit": "625e72f3-b450-40c1-aa6b-087512fcbcc9"}, "_deposit": {"created_by": 1, "id": "85007", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "85007"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00085007", "sets": ["29"]}, "author_link": ["1034556", "1034555"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2022-02-24", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Recently, targeted radionuclide therapy (TRT) with radionuclide-derived short-range radiation has been growing rapidly. Due to their nano-scale range (2–500 nm), Auger electrons (Auger e−) have the potential to induce physiochemical damage to biomolecules smaller than a single cell, meaning that it is necessary to transport Auger e−-emitting radiopharmaceuticals to cellular regions that are sensitive to Auger e−. DNA is a prime target of Auger e− TRT; however, proper drug design has remained elusive. The DNA-damaging effect of Auger e− is maximized by an efficient interaction with DNA when Auger e− emitters are as close as possible to DNA. In this regard, radio-Pt is suitable for Auger e− TRT targeting DNA efficiently because of the unique DNA-binding ability of Pt. We have established a novel production method of no-carrier–added radio-Pt (n.c.a. 191Pt emitting Auger electrons) and developed labeling methods for n.c.a. 191Pt. In this presentation, I will introduce the series of research on 191Pt from the development of 191Pt-labeled agents to their biological evaluation.\n\n", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "On the Horizon: Novel Isotopes and Future Leaders", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Honoka, Obata"}], "nameIdentifiers": [{"nameIdentifier": "1034555", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Honoka, Obata", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1034556", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Development of radio-Pt-based agents for targeted Auger electron therapy ~from radionuclide production to radio-labeling and biological evaluation", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Development of radio-Pt-based agents for targeted Auger electron therapy ~from radionuclide production to radio-labeling and biological evaluation"}]}, "item_type_id": "10005", "owner": "1", "path": ["29"], "permalink_uri": "https://repo.qst.go.jp/records/85007", "pubdate": {"attribute_name": "公開日", "attribute_value": "2022-02-16"}, "publish_date": "2022-02-16", "publish_status": "0", "recid": "85007", "relation": {}, "relation_version_is_last": true, "title": ["Development of radio-Pt-based agents for targeted Auger electron therapy ~from radionuclide production to radio-labeling and biological evaluation"], "weko_shared_id": -1}
Development of radio-Pt-based agents for targeted Auger electron therapy ~from radionuclide production to radio-labeling and biological evaluation
https://repo.qst.go.jp/records/85007
https://repo.qst.go.jp/records/850075b8cf5d9-8785-4a7e-9910-5efc0233abec
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2022-02-16 | |||||
タイトル | ||||||
タイトル | Development of radio-Pt-based agents for targeted Auger electron therapy ~from radionuclide production to radio-labeling and biological evaluation | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Honoka, Obata
× Honoka, Obata× Honoka, Obata |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Recently, targeted radionuclide therapy (TRT) with radionuclide-derived short-range radiation has been growing rapidly. Due to their nano-scale range (2–500 nm), Auger electrons (Auger e−) have the potential to induce physiochemical damage to biomolecules smaller than a single cell, meaning that it is necessary to transport Auger e−-emitting radiopharmaceuticals to cellular regions that are sensitive to Auger e−. DNA is a prime target of Auger e− TRT; however, proper drug design has remained elusive. The DNA-damaging effect of Auger e− is maximized by an efficient interaction with DNA when Auger e− emitters are as close as possible to DNA. In this regard, radio-Pt is suitable for Auger e− TRT targeting DNA efficiently because of the unique DNA-binding ability of Pt. We have established a novel production method of no-carrier–added radio-Pt (n.c.a. 191Pt emitting Auger electrons) and developed labeling methods for n.c.a. 191Pt. In this presentation, I will introduce the series of research on 191Pt from the development of 191Pt-labeled agents to their biological evaluation. | |||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | On the Horizon: Novel Isotopes and Future Leaders | |||||
発表年月日 | ||||||
日付 | 2022-02-24 | |||||
日付タイプ | Issued |